Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antigenicity study of T-3761]

T Shibata1, N Iwai, M Miyazaki

  • 1Research Laboratories, Toyama Chemical Co., Ltd., Japan.

The Japanese Journal of Antibiotics
|June 1, 1995
PubMed
Summary

Antigenicity studies indicate T-3761, a novel quinolone derivative, is not immunogenic or allergenic. Extensive testing in guinea pigs, mice, and rats confirmed T-3761 lacks significant antigenicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD4 subsets in IgA nephropathy.

The Tokai journal of experimental and clinical medicine·1992
Same author

Magnetic resonance imaging of the brain structures in the posterior fossa in retarded autistic children.

Acta paediatrica (Oslo, Norway : 1992)·1992
Same author

Antiproliferative effects of suramin on human cancer cells in vitro and in vivo.

Acta medica Okayama·1992
Same author

[Polymorphism of immunoglobulin heavy chain switch region in IgA nephropathy].

Nihon rinsho. Japanese journal of clinical medicine·1992
Same author

[Hepatic protein synthesis and cytokines in obstructive jaundice].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·1992
Same author

[Vincristine played a pivotal role in hematological remission of thrombotic thrombocytopenic purpura (T.T.P.)].

[Rinsho ketsueki] The Japanese journal of clinical hematology·1992

Area of Science:

  • Pharmacology
  • Immunology
  • Toxicology

Context:

  • Quinolone derivatives are widely used antibiotics.
  • Assessing the antigenicity of new drug candidates is crucial for safety.
  • T-3761 is a novel quinolone derivative requiring safety evaluation.

Purpose:

  • To evaluate the immunogenicity and allergenicity of T-3761.
  • To determine if T-3761 can elicit an immune response or allergic reactions.
  • To assess the potential for T-3761 to induce IgE antibody production.

Summary:

  • Active systemic anaphylaxis tests in guinea pigs showed no immunogenicity or allergenicity.
  • Passive Cutaneous Anaphylaxis (PCA) tests in guinea pigs and rats did not detect immunogenicity, allergenicity, or IgE antibody production potential.
  • Passive hemagglutination assays in rats and dogs after repeated dose toxicity studies revealed no detectable specific antibodies.

Impact:

  • These findings suggest T-3761 has a low risk of causing immune-mediated adverse reactions.
  • The study provides critical safety data for the development of T-3761.
  • Demonstrates the lack of antigenicity for a new quinolone derivative, supporting its potential therapeutic use.

Related Experiment Videos